Literature DB >> 92910

Chronic progressive myelopathy: investigation with CSF electrophoresis, evoked potentials, and CT scan.

D W Paty, W T Blume, W F Brown, N Jaatoul, A Kertesz, W McInnis.   

Abstract

Chronic progressive myelopathy (CPM) is a difficult clinical problem. Many patients who present with CPM turn out to have a spinal form of multiple sclerosis (MS), but until there is clear lesion dissemination, a definite clinical diagnosis cannot be made. We have looked for MS-related abnormalities in 72 patients with CPM. The mean age of onset was 42 years, mean duration was ten years, and mean Kurtzke disability rating was 4.5. Studies performed were cerebrospinal fluid electrophoresis for oligoclonal banding, pattern-reversal visual evoked responses, blink reflex latencies, and computerized axial tomography. Oligoclonal banding was found in 32 patients (44%), patterned visual evoked responses were abnormal in 32 (44%), and blink latencies were abnormal in 40 (56%). A least one of these studies was abnormal in 61 patients (85%) and at least two in 48 (66%). The CT scan was abnormal in 38 )53%), 36 with atrophy and 3 with low-density or enhancing lesions. These results suggest that at least 44% of patients with CPM may have MS that could be diagnosed by oligoclonal bands. Other physiological tests suggesting diffuse or disseminated disease bring the total to 85%. Only autopsy follow-up will tell us the exact diagnostic accuracy of these studies in this complex syndrome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92910     DOI: 10.1002/ana.410060508

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.

Authors:  B G Weinshenker; J J Gilbert; G C Ebers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

2.  Clinical neurophysiology in the assessment of neurological symptoms in systemic lupus erythematosus.

Authors:  A B Mongey; D Glynn; M Hutchinson; B Bresnihan
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  Chronic encephalomyelitis presenting as chronic progressive myelopathy.

Authors:  T Yamamoto; J F Llena; E S Kim; A Hirano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

4.  Detecting immunoglobulin abnormalities in the cerebrospinal fluid (CSF): which methods are best for clinical purposes?

Authors:  M A Laurenzi; L Provinciali; A R Giovagnoli; V Busco Bocchini; L Paris; F Chiodi
Journal:  Ital J Neurol Sci       Date:  1987-06

5.  Cranial computed tomography in the diagnosis of multiple sclerosis.

Authors:  L A Loizou; E B Rolfe; H Hewazy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

6.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  The value of measuring saccadic eye movement in the investigation of non-compressive myelopathy.

Authors:  M C Pitt; J M Rawles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

8.  Multiple sclerosis with clinical and radiological features of cerebral tumour.

Authors:  H J Sagar; C P Warlow; P W Sheldon; M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.